Never Run Out Of Buyers To Sell To.

BiOrion is a clinical stage biopharmaceutical company developing combined PET-imaging diagnostics and targeted radionuclide therapeutics (theranostics) for millions of patients suffering from fibrosis or fibrotic cancers. We have developed high-affinity binding single domain antibodies to PDGF-beta-receptors that appear on activated myofibroblasts in fibrotic tissue. Most companies that have developed fibrosis diagnostics focus on the deposition of extracellular matrix proteins, such as collagen. BiOrion, on the other hand, believes that fibrogenesis (fibrosis activity) is a far more reliable…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$1M to $5M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.